BHST · Bioharvest Sciences Inc. · Financials
Market Cap
$41.94M
Shares
22.67M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$34.51M
+37%
FY2025
Net Income
-$11.14M
+13.8%
FY2025
Gross Margin
59.34%
+4pp
FY2025
Operating Margin
-16.16%
+11.6pp
FY2025
Operating Cash Flow
-$7.23M
-8.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| $37M – $40M | $34.51M | $25.19M | $12.67M | |
| — | $14.03M | $11.25M | $7.04M | |
| — | $20.48M | $13.94M | $5.63M | |
| — | 59.34% | 55.35% | 44.45% | |
| — | $5.31M | $4.8M | $3.37M | |
| — | $4.93M | $4.4M | $4.48M | |
| — | $1.62M | $1.25M | $840K | |
| — | $26.05M | $20.93M | $15.6M | |
| — | -$5.58M | -$6.99M | -$9.97M | |
| — | -16.16% | -27.75% | -78.65% | |
| — | -$3.95M | -$5.74M | -$9.13M | |
| — | -$11.06M | -$12.91M | -$12.56M | |
| — | -$76K | -$8000 | $0 | |
| — | -$11.14M | -$12.91M | -$12.56M | |
| — | -32.27% | -51.27% | -99.15% | |
| USD/shares | — | -$0.60 | -$0.80 | -$0.93 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
(G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.